Literature DB >> 7931467

Combination chemotherapy in advanced prostate cancer: a silk purse?

B J Roth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7931467     DOI： 10.1200/JCO.1994.12.10.2001

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer.

Authors:  Joan Carles Galcerán; Romà Bastus Piulats; Javier Martín-Broto; Pablo Maroto Rey; Miquel Nogué Aligué; Montserrat Domenech Santasusana; Angels Arcusa Lanza; Joaquim Bellmunt Molins; Catherine Colin; Atika Girard
Journal:  Clin Transl Oncol       Date:  2005-03       Impact factor: 3.405

2.  Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer.

Authors:  M J Edelman; F J Meyers; T Grennan; J Lauder; J Doroshow
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

Review 3.  Chemotherapy and its evolving role in the management of advanced prostate cancer.

Authors:  Michael T Schweizer; Emmanuel S Antonarakis
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.